<p>On Wednesday, Mount Sinai Health System issued a <a href="https://www.mountsinai.org/about/newsroom/2020/blood-thinners-may-improve-survival-among-hospitalized-covid19-patients-pr">press release</a> about a recent observational study that appears to show a significant benefit to treating severe hospitalized COVID-19 patients with anticoagulant (blood thinning) medications.</p>
<p>According to the release, “a team of investigators evaluated records of 2,773 confirmed COVID-19-positive patients admitted to five hospitals in the Mount Sinai Health System in New York City &#8230; between March 14 and April 11, 2020.”</p>
<p>While considering other “risk factors” including but not limited to whether or not the patient was already on blood thinners, the team examined the “survival rates” for COVID-19 patients who were given anticoagulants verses those who were not.</p>
<p>The results were eye-opening.</p>
<p>Approximately 28% of the patients under examination were found to have been given “a full-treatment dose of anticoagulants – a higher dose than what is typically given for blood clot prevention, and one that is usually given to those who already have clots or are suspected to have clots.”</p>
<p>It appears as though COVID-19 patients who were given anticoagulants fared better than their counterparts. Not only did patients on blood thinners stay alive longer in general, but those on ventilators who were given anticoagulants appeared more likely to survive the illness.</p>
<p>“62.7 percent of intubated patients who were not treated with anticoagulants died, compared to 29.1 percent for intubated patients treated with anticoagulants,” the release states.</p>
<p>This chart shows the impact:</p>
<div id="attachment_110782" style="width: 780px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-110782" class="size-full wp-image-110782" src="https://editorial.dailywire.com/wp-content/uploads/2020/05/85D8D6FA-6A11-4236-BEAB-E452CC07104B.png" alt="Blood thinner chart." width="770" height="420" srcset="https://dw-wp-production.imgix.net/2020/05/85D8D6FA-6A11-4236-BEAB-E452CC07104B.png 770w, https://dw-wp-production.imgix.net/2020/05/85D8D6FA-6A11-4236-BEAB-E452CC07104B-300x164.png 300w, https://dw-wp-production.imgix.net/2020/05/85D8D6FA-6A11-4236-BEAB-E452CC07104B-768x419.png 768w" sizes=" (max-width: 770px) 100vw, 770px" /><p id="caption-attachment-110782" class="wp-caption-text">Mount Sinai Health System</p></div>
<p>President and Chief Operating Officer of The Mount Sinai Hospital David Reich, MD, said: “We are hopeful that this report of the association of anticoagulation therapy with improved survival will be confirmed in future investigations.”</p>
<p>Anu Lala, MD, Assistant Professor of Medicine (Cardiology) at the Icahn School of Medicine at Mount Sinai, noted that having treated COVID-19 patients for weeks, she has seen “an increased amount of blood clot cases,” adding that “further analysis and prospective studies” will be necessary in order to establish the potential benefits of anticoagulants in those hospitalized with the virus.</p>
<p>Stating that he is “excited” about the initial results, senior author Girish Nadkarni, MD, Co-Director of the Mount Sinai COVID Informatics Center, spoke about what’s next on the docket:</p>
<blockquote><p>This study is opening the door for a more extensive study that will be carried out with 5,000 COVID-19-positive patients, where we will evaluate the effectiveness of three types of antithrombotic therapy – oral antithrombotic, subcutaneous heparin, and intravenous heparin – and then perhaps engage our data for prospective clinical trials.</p></blockquote>
<p>The Daily Wire reached out to the medical team responsible for the study, but were unable to secure comment or quotes prior to publication.</p>
<p>In an April 8 <a href="https://www.dailywire.com/news/interview-emergency-medicine-doc-in-nyc-talks-covid-19-how-its-different-than-the-flu-and-what-hes-seeing-on-the-ground">interview</a> with The Daily Wire, Dr. Zachary Blankenship, DO, of St. Barnabas Hospital in the Bronx, noted blood-related issues he was seeing in his patients:</p>
<blockquote><p>All of my patients have deranged laboratory values, like abnormal electrolytes, kidney failure, liver failure. There seems to be some effect on your blood’s ability to clot and break down clots, which is at a constant balance. And so I’ve seen a ton of people who have blood clots. They’re getting blood clots in the brain, which we call a stroke, blood clots in the heart, or a heart attack. I’ve seen people with blood clots in the leg, too. I’ve also seen patients with bleeding, gastrointestinal bleeding, blood in the urine.</p></blockquote>
<p>The full press release can be read <a href="https://www.mountsinai.org/about/newsroom/2020/blood-thinners-may-improve-survival-among-hospitalized-covid19-patients-pr">here</a>.</p>
<p><i>The Daily Wire, headed by bestselling author and popular podcast host Ben Shapiro, is a leading provider of conservative news, cutting through the mainstream media’s rhetoric to provide readers the most important, relevant, and engaging stories of the day. Get inside access to The Daily Wire by becoming a <a href="https://www.dailywire.com/subscribe">member</a>.</i></p>

<script async src="https://www.instagram.com/embed.js"></script>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
<script async src="https://www.tiktok.com/embed.js"></script><div data-widget-host="revcontent" data-pub-id="165152" data-widget-id="290588"></div><script src="https://delivery.revcontent.com/165152/290588/widget.js"></script>

Anticoagulants Could Help Hospitalized COVID-19 Patient Survival, Research Finds

Ilhan Omar Comes Under Financial Scrutiny — Now Husband’s Winery Suddenly Goes Dark

Trump Stokes UFO Frenzy With New Promise

Astronauts Reveal Something No Human Has Ever Seen On Far Side Of Moon

Israeli Ambassador Reacts To Iran Strike With Message That Raises Stakes

Tom Homan Lays Out What Americans Can Expect As ICE Moves Into Airports Monday

VIDEO: Iranian Missile Screams Over Israel, Explosion Injures Dozens, Including Children

News and Commentary

COVID

A video goes viral showing a baby being refused his mother by two gay "dads". This is just the tip of the iceberg, which is why we will have an important discussion today about surrogacy. 

Hour 1

The Matt Walsh Show

Ep. 1765 - This Video Is One Of The Worst Things I've Seen In A Long Time 

The Strait of Hormuz officially opens for business (kind of), the Pope makes “shocking” comments on immigration, and President Trump promises UFO disclosure at TPUSA. 


The Michael Knowles Show

Ep. 1956 -  Pope Leo's "SHOCKING" Immigration Comments EXPLAINED

A false miscreed has corrupted our leadership class.


The Andrew Klavan Show

Ep. 1275 - Dumb, Dumber and Progressive

President Trump announces a 10-day ceasefire between Lebanon and Israel, a murder-suicide involving former Democratic Lieutenant Governor Justin Fairfax shakes Virginia, and France and Britain hold a conference to secure the Strait of Hormuz – after the Iranian conflict ends. Get the facts first with Morning Wire.

- - -

Ep. 2738

- - -

Wake up with new Morning Wire merch: https://bit.ly/4lIubt3

- - -

Today's Sponsors:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text 'WIRE' to 83848 to learn more.

Pocket Hose - Text MORNING to 64000 to get a FREE pocket pivot and their 10-pattern sprayer with the purchase of ANY size Copper Head hose. Message and data rates may apply.

Morning Wire

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26

U.S. Expands Hormuz Blockade & VA Fairfax Deaths Investigated | 4.17.26 [Member Exclusive]

A ceasefire goes into effect between Israel and Lebanon, a tragic murder-suicide rocks Virginia, and Dairy Queen deploys AI in the drive-thru. Get the facts first with Evening Wire.
- - -
Ep. 2737
- - -
Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 
- - -
Today’s Sponsor:

Alliance Defending Freedom - Visit https://JoinADF.com/WIRE or text “WIRE” to 83848 to learn more.


Menu

— News and Commentary —

Anticoagulants Could Help Hospitalized COVID-19 Patient Survival, Research Finds